The rates of isolation of Mycoplasma species from bronchoalveolar lavages of human immunodeficiency virus (H1V)-infected patients and HIV-negative patients were compared. Mycoplasma species were more frequently isolated from HIV-positive patients. In most cases, a known pulmonary pathogen was also identified. All samples tested negative for Mycoplasma fermentans by PCR.
Mycoplasma species have been proposed as important cofactors in human immunodeficiency virus (HIV) infection. Lo et al. (9, 11, 12) have documented the presence of Mycoplasma fermentans incognitus strain immunohistochemically and by PCR in the organs of several HIV-positive patients at the time of autopsy. Other investigators have demonstrated M. fermentans DNA by PCR in urine and blood samples from HIVinfected patients but not from HIV-negative controls (4, 5) . In addition, Lo et al. (10) have detected a new Mvcoplasma species, Mycoplasma penetrans, serologically and from urine samples of a number of HIV-infected people. In vitro studies indicate that there is synergism between HIV and M. fermentans and Mycoplasma pirum and that this synergism promotes the cytocidal replication of the virus in lymphocyte cultures (7, 8, 13, 15) .
To assess the prevalence of mycoplasmas in the lower respiratory tract, 94 consecutive bronchoalveolar lavage (BAL) samples from 77 patients were cultured for mycoplasmas. Fluid was plated directly onto SP4 agar and was serially diluted 10-fold to 10-7 in SP4 broth and then incubated aerobically at 35°C with 5% CO2 and anaerobically for 6 weeks (21, 22) .
The contents of broth tubes were observed for pH shifts, and they were subcultured onto SP4 agar if there was evidence of growth. Broth cultures not exhibiting pH changes were subcultured blindly at 7 days and 4 weeks. Mycoplasma species were identified by growth inhibition by using species-specific antisera (2, 3) .
Eighty-nine of the samples were submitted to Shyh-Ching Lo at the Armed Forces Institute of Pathology for M. fermentans PCR as described elsewhere (6 HIV-positive group was 35 years, with a range of 27 to 67 years, and men outnumbered women 5:1. All of the HIV-infected patients had AIDS (19) .
In contrast, the HIV-negative group was older and had a broader range of ages (8 months to 80 years), and men outnumbered women by 3:1. Twenty-nine of the 38 HIVnegative patients had underlying conditions which predisposed them to pulmonary disease, including leukemia, lymphoma and other cancers, chronic pulmonary diseases, diabetes, congestive heart failure, alcoholism, lupus erythematosus, or immunosuppression for transplantation.
Of the 94 specimens cultured, 17 (18%) grew mycoplasmas.
The HIV-positive population accounted for 13 of these positive cultures, whereas the HIV-negative group accounted for 4 of these positive cultures. One HIV-positive patient was culture positive simultaneously for both Mycoplasma pneumoniae and Mycoplasma salivarium. Three BALs from another HIV- (20) . The greater frequency of occurrence of M. salivanium in HIVinfected versus that in HIV-negative patients was also observed in a study of periodontal microflora in which HIVpositive patients with adult periodontitis showed a significantly higher rate of M. salivarium infection than did HIV-negative patients with adult periodontitis (16) . The complex oral ecology of HIV-positive patients may somehow encourage colonization with M. salivarium.
Mycoplasma orale was not identified in either group, although it, too, is a commensal organism in the human oral cavity. However, the colonization rate of M. orale in adults is somewhat lower than that of M. salivarium; M. orale is seen in the respiratory tracts of 30 to 60% of adults (20) .
The role of Mycoplasma hominis in the respiratory tract is not clear. It was isolated more frequently in HIV-infected patients than in patients not infected with HIV, which is consistent with other recent findings that implicate M. hominis in extragenital infections in adults, particularly in patients with suppressed cell-mediated immunity or hypogammaglobulinemia (14) . We speculated that the carriage of M. hominis in the respiratory tract might also have been a factor of age or sexual activity, which could not be evaluated in the two study populations.
Only one case of M. pneumoniae pneumonia was detected. Although pneumonia caused by M. pneumoniae is not frequently associated with HIV infection, it should be considered, especially among individuals in the age group from 5 to 25 years, among whom M. pneumoniae pneumonia is most prevalent in the general population (18) .
M. fermentans was not detected in any of the samples by culture or PCR. The negative PCR findings are in contrast to data obtained by Katseni et al. (6) . Throat swabs of HIVpositive and HIV-negative patients seen in a sexually transmitted disease clinic were positive for M. fernentans (23 and 20%, respectively) . They theorized that the throat is the primary site of colonization with M. fermentans in these two groups, which were mainly made up of homosexual men. Although some contamination by organisms of the upper respiratory tract is expected in BAL samples, there may be other patient factors that affect the carriage rate of M. fermentans, which differed between the homosexual men at the sexually transmitted disease clinic tested in the study of Katseni et al. (6) and the hospitalized population that we sampled, including community exposure, sexual activity, and prior antibiotic therapy.
Review of the other microbiological results obtained from these two populations showed that the rates of isolation of Pneumocystis carinii, cytomegalovirus, Mycobacterium aviumMycobacterium intracellulare, Staphylococcus aureus, Candida albicans, and Streptococcus pneumoniae were also greater for the HIV-positive population than for the HIV-negative population, as was expected (17, 23) .
In addition to Mycoplasma species, a possible or probable pulmonary pathogen was isolated from 10 of the 11 HIVpositive patients and 2 of 4 HIV-negative patients (Table 2) . We could not suggest an association of these organisms alone with pulmonary disease in either population.
Because of the evidence of direct renal pathology associated with M. fermentans in the case of AIDS nephropathy (1) and the considerable speculation that mycoplasmas are cofactors in the development of systemic AIDS, we felt that it was important to screen lower respiratory tract specimens of those HIV-infected and non-HIV-infected patients who had significant pulmonary disease for mycoplasmas as well. Our inability to recover M. fermentans or genetic evidence of it from any of our samples does not address the potential interactive role of these bacteria with HIV infection and the immune system, but it does diminish our concern that Mycoplasma species other that M. pneumoniae contribute directly to pulmonary disease in HIV-infected and non-HIV-infected patients.
